Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma.
BMC Cancer. 2023 Oct 3;23(1):934. doi: 10.1186/s12885-023-11401-4.
BMC Cancer. 2023.
PMID: 37789275
Free PMC article.
BACKGROUND: Recent studies have indicated that epigenetic alterations contribute significantly to lymphoma pathogenesis. A type of epigenetic regulation known as histone acetylation plays a crucial role in transcriptional regulation in eukaryotic cells. Specifically, a sig …
BACKGROUND: Recent studies have indicated that epigenetic alterations contribute significantly to lymphoma pathogenesis. A type of ep …
KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway.
Chen X, Lu T, Cai Y, Han Y, Ding M, Chu Y, Zhou X, Wang X.
Chen X, et al.
Cell Mol Biol Lett. 2023 Apr 19;28(1):32. doi: 10.1186/s11658-023-00445-w.
Cell Mol Biol Lett. 2023.
PMID: 37076815
Free PMC article.
However, the function of m6A modification mediated by KIAA1429 [alias virus-like m6A methyltransferase-associated protein (VIRMA)] during the progression of diffuse large B-cell lymphoma (DLBCL) remains undefined. METHODS: The expression and clinical significance of KIAA14 …
However, the function of m6A modification mediated by KIAA1429 [alias virus-like m6A methyltransferase-associated protein (VIRMA)] during th …
Item in Clipboard
Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
Chen X, Hu S, Han Y, Cai Y, Lu T, Hu X, Chu Y, Zhou X, Wang X.
Chen X, et al.
Clin Exp Med. 2023 Oct;23(6):2601-2617. doi: 10.1007/s10238-023-00996-4. Epub 2023 Jan 22.
Clin Exp Med. 2023.
PMID: 36682001
Diffuse large B cell lymphoma (DLBCL) is a usual-seen hematological malignant tumor possessing molecular and genetic heterogeneity. ...
Diffuse large B cell lymphoma (DLBCL) is a usual-seen hematological malignant tumor possessing molecular and genetic heterogeneity. . …
Item in Clipboard
m6A binding protein YTHDF2 in cancer.
Chen X, Zhou X, Wang X.
Chen X, et al.
Exp Hematol Oncol. 2022 Apr 5;11(1):21. doi: 10.1186/s40164-022-00269-y.
Exp Hematol Oncol. 2022.
PMID: 35382893
Free PMC article.
Review.
Item in Clipboard
Cite
Cite